NCT04289337

Double-blind Clinical Trials of Probiotic Products in Oral Health.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 130 (actual)
• Sponsor: Glac Biotech Co., Ltd · Industry
• Sex: All
• Age: 20 Years – 40 Years
• Healthy volunteers: Accepted

Summary

In order to evaluate the effects of supplementary probiotics and their metabolites on oral environment and oral microbiota, Taiwan FDA No. 88037803 will be used to evaluate the effects of oral probiotic candidate strains from previous research results and develop oral probiotic products.

Conditions

• Probiotics
• Oral Health
• Probiotic Metabolites

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Combined probiotics (1)	Subjects used one oral combined probiotics (1) tablet each morning, noon, and evening for 4 weeks.
DIETARY_SUPPLEMENT	Combined probiotics (2)	Subjects used one oral combined probiotics (2) tablet each morning, noon, and evening for 4 weeks.
DIETARY_SUPPLEMENT	Combined heat-killed probiotics (1)	Subjects used one oral combined heat-killed probiotics (1) tablet each morning, noon, and evening for 4 weeks.
DIETARY_SUPPLEMENT	Combined heat-killed probiotics (2)	Subjects used one oral combined heat-killed probiotics (2) tablet each morning, noon, and evening for 4 weeks.
DIETARY_SUPPLEMENT	Probiotic metabolites	Subjects used one oral probiotic metabolites tablet each morning, noon, and evening for 4 weeks.
DIETARY_SUPPLEMENT	Placebo	Subjects used one oral placebo tablet each morning, noon, and evening for 4 weeks.

Timeline

• Start date: 2019-10-21
• Primary completion: 2019-12-02
• Completion: 2019-12-06
• First posted: 2020-02-28
• Last updated: 2020-02-28

Locations

1 site across 1 country: Taiwan